Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma

Table 1

The relationship of FEN1 expression in HCC with clinicopathological characteristics.

Characteristics		FEN1
		Low	High	value
Sex	Female	136 (51.9%)	126 (48.1%)	0.715
	Male	37 (49.3%)	38 (50.7%)
Age	<50	65 (52%)	60 (48%)	0.851
	≥50	108 (50.9%)	104 (49.1%)
Liver cirrhosis	Present	160 (51.3%)	152 (48.7%)	0.945
	Absent	13 (52%)	12 (48%)
AFP	<20	82 (50%)	82 (50%)	0.633
	≥20	91 (52.6%)	82 (47.4%)
Tumor multiplicity	Multiple	43 (54.4%)	36 (45.6%)	0.529
	Single	130 (50.4%)	128 (49.6%)
Pathologic TNM stage	I/II	168 (63.4%)	97 (36.6%)	<0.001
	III/IV	17 (23.61%)	55 (76.39%)